Persistence of mucosal and systemic immune responses following sublingual immunization. 2010

Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
Department of Infectious, Parasitic and Immune-mediated Diseases, Istituto Superiore di Sanità, Viale Regina Elena 299, 00161 Rome, Italy. donatella.negri@iss.it

The development of mucosal vaccines for prevention of infectious diseases caused by pathogens entering through the mucosal surfaces is an important and challenging objective. To this purpose, we evaluated the efficacy and durability of immune response induced by sublingual immunization with tetanus toxoid (TT) as an antigen in the presence of mucosal adjuvants, such as E. coli Heat-Labile enterotoxin (LT) or the mutant of LT lacking ADP ribosyltransferase activity (LTK63). Both serum anti-TT IgG and mucosal anti-TT IgA antibodies reached a peak after four immunizations and decreased over time, maintaining detectable titers up to 4 months after the last immunization. Similarly, antigen-specific antibody secreting cells in bone marrow and TT-specific CD4+ and CD8+ T cells in draining lymph nodes and spleen were present up to 4 months from the last immunization. Overall, LT-treated mice showed significantly higher responses compared to LTK63 immunized mice. The efficacy and persistence of the immune response induced by sublingual immunization with different adjuvants strongly suggest that this route represents an appealing and promising alternative to the other mucosal routes of vaccine delivery.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008807 Mice, Inbred BALB C An inbred strain of mouse that is widely used in IMMUNOLOGY studies and cancer research. BALB C Mice, Inbred,BALB C Mouse, Inbred,Inbred BALB C Mice,Inbred BALB C Mouse,Mice, BALB C,Mouse, BALB C,Mouse, Inbred BALB C,BALB C Mice,BALB C Mouse
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow
D004768 Enterotoxins Substances that are toxic to the intestinal tract causing vomiting, diarrhea, etc.; most common enterotoxins are produced by bacteria. Staphylococcal Enterotoxin,Enterotoxin,Staphylococcal Enterotoxins,Enterotoxin, Staphylococcal,Enterotoxins, Staphylococcal
D005260 Female Females
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000286 Administration, Sublingual Administration of a soluble dosage form by placement under the tongue. Drug Administration, Sublingual,Sublingual Drug Administration,Sublingual Administration,Administration, Sublingual Drug,Administrations, Sublingual,Administrations, Sublingual Drug,Drug Administrations, Sublingual,Sublingual Administrations,Sublingual Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000907 Antibodies, Bacterial Immunoglobulins produced in a response to BACTERIAL ANTIGENS. Bacterial Antibodies
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
December 2007, Vaccine,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
February 2021, Vaccines,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
April 2018, Auris, nasus, larynx,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
October 2021, Tropical medicine and infectious disease,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
August 1995, Immunological investigations,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
June 2001, Oral microbiology and immunology,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
February 2017, Immunology,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
May 2012, Microbes and infection,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
December 1975, Immunology,
Donatella R M Negri, and Antonella Riccomi, and Dora Pinto, and Silvia Vendetti, and Alessandra Rossi, and Rosella Cicconi, and Paolo Ruggiero, and Giuseppe Del Giudice, and Maria Teresa De Magistris
December 2007, Vaccine,
Copied contents to your clipboard!